Milestone Scientific, Inc. Common Stock (MLSS) — 分析摘要
Milestone Scientific, Inc. Common Stock（MLSS）的市值为34.89百万美元，最近一年的营收同比增长了+4.0%。净利润率为-63.8%。当前市盈率为-7.6倍。
核心要点
- 营收同比变化+4.0%
- 净利润率-63.8%
- 市盈率-7.6倍
与ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES板块的其他公司相比，MLSS的营收增长为+4.0%，市盈率为-7.6倍。
Milestone Scientific, Inc. Common Stock (MLSS)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
营业利润率为 -50.8% — 严重经营亏损
净利率为 -51.3% — 亏损显著
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
行业
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
员工人数
15
总部
LIVINGSTON, NJ
Exchange
XASE
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。